Steve Wise

Partner, Managing Director and Global Head of Healthcare, Carlyle

Steve Wise is a Managing Director and Head of Global Healthcare for Carlyle. He is based in New York. Since joining Carlyle in 2006, Steve has led or been a key contributor to several Carlyle investments including Curia Global, CorroHealth, Medline, MedRisk, MultiPlan, Millicent Pharma, QuidelOrtho, PPD, Rede D’Or São Luiz S.A., Resonetics, TriNetX, Unchained Labs, and WellDyneRx. He also leads Carlyle’s broader life sciences efforts, including the recent acquisition of Abingworth. Prior to joining Carlyle, Steve worked with JLL Partners, a New York‐based private equity firm, where he focused on healthcare‐related investments. Previously, he worked with J.W. Childs Associates, a Boston‐based private equity firm, and prior to that, in the leveraged finance group of Credit Suisse. Steve serves as a director on the boards of Curia Global, Medline, Resonetics, and Sedgwick. Steve also serves on the Leadership Council of the Harvard School of Public Health. Steve received his M.B.A. from Harvard Business School and a B.A. in economics and finance from Bucknell University.